Huansha Yu

机构：Shanghai Pulmonary Hospital

发表论文 61 篇 · 总被引 2529 次 · h-index 20

代表论文

• Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing (2023 · Genome Medicine · 被引 400)
• Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies (2024 · Cell · 被引 189)
• Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer (2024 · Nature Genetics · 被引 146)
• Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study (2023 · Nature Communications · 被引 46)
• Ferroptosis and Pyroptosis Co‐Activated Nanomodulator for “Cold” Tumor Immunotherapy and Lung Metastasis Inhibition (2023 · Advanced Functional Materials · 被引 41)
• Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II–III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study (2024 · Signal Transduction and Targeted Therapy · 被引 35)